Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.

Listen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

The health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance ...

Ozempic, while effective for weight loss, is linked to emerging dental problems termed \"Ozempic teeth.\" Patients report dry ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...